Assessment of Oral Chemotherapy Nonadherence in Chronic Myeloid Leukemia Patients Using Brief Measures in Community Cancer Clinics: A Pilot Study
The purpose of this pilot study was to assess Chronic Myeloid Leukemia (CML) patients’ adherence to, beliefs about, and barriers to oral anticancer agents (OAC) using brief self-report measures in community-based cancer clinics. Patients completed a structured interview including a health literacy a...
Guardado en:
Autores principales: | Terry C. Davis, Connie L. Arnold, Glenn Mills, Glenn J. Lesser, W. Mark Brown, Richard Schulz, Kathryn E. Weaver, Pamala A. Pawloski |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9fd899074d48423bbfe08aae834277a1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Priapism as the first manifestation in chronic myeloid leukemia: A case report and focused review of literature
por: Claudia Lucia Sossa Melo, et al.
Publicado: (2021) -
Isolation of Mycobacterium branderi, an unusual species from an acute myelogenous leukemia patient
por: Majid Marjani, et al.
Publicado: (2014) -
Update on the management of Philadelphia chromosome positive chronic myelogenous leukemia: role of nilotinib
por: Emole J, et al.
Publicado: (2016) -
Myeloid sarcoma: an uncommon presentation of myeloid neoplasms; a case series of 4 rare cases reported in a tertiary care institute
por: Toyaja Jadhav, et al.
Publicado: (2021) -
JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia
por: Haidée Aranda-Tavío, et al.
Publicado: (2021)